| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.NEUROBIOLAGING.2013.03.029 |
| P698 | PubMed publication ID | 23623603 |
| P50 | author | Michael Chopp | Q71037672 |
| P2093 | author name string | Tae Hee Lee | |
| Ji-Min Park | |||
| Hyun-Seob Lee | |||
| Jisook Moon | |||
| Hyun Sook Kim | |||
| Mi-Kyung Park | |||
| Han Wool Kim | |||
| Kyung-Sul Kim | |||
| Dae Seog Lim | |||
| P433 | issue | 10 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 2408-2420 | |
| P577 | publication date | 2013-04-24 | |
| P1433 | published in | Neurobiology of Aging | Q7002141 |
| P1476 | title | Long-term immunomodulatory effect of amniotic stem cells in an Alzheimer's disease model | |
| P478 | volume | 34 |
| Q33667926 | Alzheimer's disease, dementia, and stem cell therapy. |
| Q91905486 | Amelioration of Alzheimer's disease pathology and cognitive deficits by immunomodulatory agents in animal models of Alzheimer's disease |
| Q38843285 | Amniotic Mesenchymal Stem Cells Decrease Aβ Deposition and Improve Memory in APP/PS1 Transgenic Mice |
| Q52568314 | Current Perspectives regarding Stem Cell-Based Therapy for Alzheimer's Disease. |
| Q55305444 | Decipher reliable biomarkers of brain aging by integrating literature-based evidence with interactome data. |
| Q32179826 | Dental pulp stem cells promote regeneration of damaged neuron cells on the cellular model of Alzheimer's disease |
| Q38400864 | Double-Injected Human Stem Cells Enhance Rehabilitation in TBI Mice Via Modulation of Survival and Inflammation. |
| Q64867912 | Dual Effects of Human Placenta-Derived Neural Cells on Neuroprotection and the Inhibition of Neuroinflammation in a Rodent Model of Parkinson's Disease |
| Q52722087 | Effect of Placenta-Derived Mesenchymal Stem Cells in a Dementia Rat Model via Microglial Mediation: a Comparison between Stem Cell Transplant Methods. |
| Q92405439 | Effect of hCMSCs and liraglutide combination in ALI through cAMP/PKAc/β-catenin signaling pathway |
| Q47882404 | Effect of systemic transplantation of bone marrow-derived mesenchymal stem cells on neuropathology markers in APP/PS1 Alzheimer mice |
| Q89018777 | Effects of mesenchymal stem cells transplantation on cognitive deficits in animal models of Alzheimer's disease: A systematic review and meta-analysis |
| Q35837904 | Effects of stem cell transplantation on cognitive decline in animal models of Alzheimer's disease: A systematic review and meta-analysis. |
| Q64261478 | HIF1α-mediated AIMP3 suppression delays stem cell aging via the induction of autophagy |
| Q27301095 | Health Span-Extending Activity of Human Amniotic Membrane- and Adipose Tissue-Derived Stem Cells in F344 Rats |
| Q57041817 | Human neural stem cell transplantation improves cognition in a murine model of Alzheimer's disease |
| Q47867948 | Immunomodulatory effect of CD200-positive human placenta-derived stem cells in the early phase of stroke |
| Q29994669 | Immunomodulatory oligonucleotide IMT504: Effects on mesenchymal stem cells as a first-in-class immunoprotective/immunoregenerative therapy |
| Q38601445 | Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications |
| Q50051077 | Inflammation, mesenchymal stem cells and bone regeneration |
| Q53590154 | Long-term kinetics of AA amyloidosis and effects of inflammatory restimulation after disappearance of amyloid depositions in mice. |
| Q50899701 | Longitudinal study of experimental induction of AA amyloidosis in mice seeded with homologous and heterologous AA fibrils. |
| Q36413131 | Microglia-targeted stem cell therapies for Alzheimer disease: A preclinical data review |
| Q92573469 | Modelling mitochondrial dysfunction in Alzheimer's disease using human induced pluripotent stem cells |
| Q38843840 | Moving from the Dish to the Clinical Practice: A Decade of Lessons and Perspectives from the Pre-Clinical and Clinical Stem Cell Studies for Alzheimer's Disease |
| Q48729092 | Multiple systemic transplantations of human amniotic mesenchymal stem cells exert therapeutic effects in an ALS mouse model |
| Q93079510 | Neurodegeneration and Neuro-Regeneration-Alzheimer's Disease and Stem Cell Therapy |
| Q92652983 | New treatment modalities in Alzheimer's disease |
| Q47773573 | Nrf2 transfection enhances the efficacy of human amniotic mesenchymal stem cells to repair lung injury induced by lipopolysaccharide. |
| Q47437348 | Pericyte implantation in the brain enhances cerebral blood flow and reduces amyloid-β pathology in amyloid model mice. |
| Q55220429 | Placenta and Placental Derivatives in Regenerative Therapies: Experimental Studies, History, and Prospects. |
| Q64983057 | Placenta-Derived Adherent Stromal Cell Therapy for Hematopoietic Disorders: A Case Study of PLX-R18. |
| Q38510227 | Placental-derived stem cells: Culture, differentiation and challenges |
| Q64230072 | Potential Therapeutic Features of Human Amniotic Mesenchymal Stem Cells in Multiple Sclerosis: Immunomodulation, Inflammation Suppression, Angiogenesis Promotion, Oxidative Stress Inhibition, Neurogenesis Induction, MMPs Regulation, and Remyelination |
| Q38772566 | Potential for Stem Cells Therapy in Alzheimer's Disease: Do Neurotrophic Factors Play Critical Role? |
| Q38324410 | Potential of neural stem cell-based therapies for Alzheimer's disease |
| Q38425315 | Retinal Angiogenesis Effects of TGF-β1 and Paracrine Factors Secreted From Human Placental Stem Cells in Response to a Pathological Environment |
| Q38757929 | Secretome Cues Modulate the Neurogenic Potential of Bone Marrow and Dental Stem Cells |
| Q38938919 | Stem Cell Therapy for Alzheimer's Disease: A Review of Recent Clinical Trials |
| Q28069506 | Stem Cell Therapy: A Prospective Treatment for Alzheimer's Disease |
| Q99579313 | Stem cell therapy for Alzheimer's disease |
| Q90627086 | Stem cell therapy in Alzheimer's disease: possible benefits and limiting drawbacks |
| Q89146080 | Stem cells technology: a powerful tool behind new brain treatments |
| Q90361854 | Stem cells: a promising candidate to treat neurological disorders |
| Q38185612 | Stem-cell challenges in the treatment of Alzheimer's disease: a long way from bench to bedside |
| Q34153594 | Targeting β-secretase with RNAi in neural stem cells for Alzheimer's disease therapy |
| Q27004398 | The Regenerative Role of the Fetal and Adult Stem Cell Secretome |
| Q41180607 | Therapeutic potential of human amniotic membrane-derived mesenchymal stem cells in APP transgenic mice |
| Q48652450 | Transplantation of Human Amniotic Mesenchymal Stem Cells Promotes Functional Recovery in a Rat Model of Traumatic Spinal Cord Injury |
| Q39102872 | Transplantation of purified autologous leukapheresis-derived CD34+ and CD133+ stem cells for patients with chronic spinal cord injuries: long-term evaluation of safety and efficacy |
| Q50577170 | Wharton's Jelly-derived mesenchymal stem cells alleviate memory deficits and reduce amyloid-β deposition in an APP/PS1 transgenic mouse model. |
Search more.